Global Pertussis Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pertussis Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pertussis Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pertussis Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Pertussis Vaccine Segment by Type

2.2.1 Whole-cell Vaccines

2.2.2 Acellular Vaccines

2.3 Pertussis Vaccine Sales by Type

2.3.1 Global Pertussis Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Pertussis Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pertussis Vaccine Sale Price by Type (2017-2022)

2.4 Pertussis Vaccine Segment by Application

2.4.1 12 Months Below

2.4.2 12 Months Above

2.5 Pertussis Vaccine Sales by Application

2.5.1 Global Pertussis Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Pertussis Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pertussis Vaccine Sale Price by Application (2017-2022)

3 Global Pertussis Vaccine by Company

3.1 Global Pertussis Vaccine Breakdown Data by Company

3.1.1 Global Pertussis Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Pertussis Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Pertussis Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Pertussis Vaccine Revenue by Company (2020-2022)

3.2.2 Global Pertussis Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Pertussis Vaccine Sale Price by Company

3.4 Key Manufacturers Pertussis Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pertussis Vaccine Product Location Distribution

3.4.2 Players Pertussis Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pertussis Vaccine by Geographic Region

4.1 World Historic Pertussis Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Pertussis Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pertussis Vaccine Annual Revenue by Geographic Region

4.2 World Historic Pertussis Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Pertussis Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pertussis Vaccine Annual Revenue by Country/Region

4.3 Americas Pertussis Vaccine Sales Growth

4.4 APAC Pertussis Vaccine Sales Growth

4.5 Europe Pertussis Vaccine Sales Growth

4.6 Middle East & Africa Pertussis Vaccine Sales Growth

5 Americas

5.1 Americas Pertussis Vaccine Sales by Country

5.1.1 Americas Pertussis Vaccine Sales by Country (2017-2022)

5.1.2 Americas Pertussis Vaccine Revenue by Country (2017-2022)

5.2 Americas Pertussis Vaccine Sales by Type

5.3 Americas Pertussis Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pertussis Vaccine Sales by Region

6.1.1 APAC Pertussis Vaccine Sales by Region (2017-2022)

6.1.2 APAC Pertussis Vaccine Revenue by Region (2017-2022)

6.2 APAC Pertussis Vaccine Sales by Type

6.3 APAC Pertussis Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pertussis Vaccine by Country

7.1.1 Europe Pertussis Vaccine Sales by Country (2017-2022)

7.1.2 Europe Pertussis Vaccine Revenue by Country (2017-2022)

7.2 Europe Pertussis Vaccine Sales by Type

7.3 Europe Pertussis Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pertussis Vaccine by Country

8.1.1 Middle East & Africa Pertussis Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pertussis Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Pertussis Vaccine Sales by Type

8.3 Middle East & Africa Pertussis Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccine

10.3 Manufacturing Process Analysis of Pertussis Vaccine

10.4 Industry Chain Structure of Pertussis Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pertussis Vaccine Distributors

11.3 Pertussis Vaccine Customer

12 World Forecast Review for Pertussis Vaccine by Geographic Region

12.1 Global Pertussis Vaccine Market Size Forecast by Region

12.1.1 Global Pertussis Vaccine Forecast by Region (2023-2028)

12.1.2 Global Pertussis Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pertussis Vaccine Forecast by Type

12.7 Global Pertussis Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi Pasteur

13.1.1 Sanofi Pasteur Company Information

13.1.2 Sanofi Pasteur Pertussis Vaccine Product Offered

13.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Pasteur Main Business Overview

13.1.5 Sanofi Pasteur Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Pertussis Vaccine Product Offered

13.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Mitsubishi Tanabe Pharma

13.3.1 Mitsubishi Tanabe Pharma Company Information

13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Offered

13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mitsubishi Tanabe Pharma Main Business Overview

13.3.5 Mitsubishi Tanabe Pharma Latest Developments

13.4 Wuhan Institute of Biological Products

13.4.1 Wuhan Institute of Biological Products Company Information

13.4.2 Wuhan Institute of Biological Products Pertussis Vaccine Product Offered

13.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Wuhan Institute of Biological Products Main Business Overview

13.4.5 Wuhan Institute of Biological Products Latest Developments

13.5 Walvax Biotechnology

13.5.1 Walvax Biotechnology Company Information

13.5.2 Walvax Biotechnology Pertussis Vaccine Product Offered

13.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Walvax Biotechnology Main Business Overview

13.5.5 Walvax Biotechnology Latest Developments

13.6 Minhai Biotechnology

13.6.1 Minhai Biotechnology Company Information

13.6.2 Minhai Biotechnology Pertussis Vaccine Product Offered

13.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Minhai Biotechnology Main Business Overview

13.6.5 Minhai Biotechnology Latest Developments

13.7 KM Biologics

13.7.1 KM Biologics Company Information

13.7.2 KM Biologics Pertussis Vaccine Product Offered

13.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 KM Biologics Main Business Overview

13.7.5 KM Biologics Latest Developments

13.8 Chengdu Institute of Biological Products

13.8.1 Chengdu Institute of Biological Products Company Information

13.8.2 Chengdu Institute of Biological Products Pertussis Vaccine Product Offered

13.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Chengdu Institute of Biological Products Main Business Overview

13.8.5 Chengdu Institute of Biological Products Latest Developments

14 Research Findings and Conclusion

Table 1. Pertussis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pertussis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Whole-cell Vaccines

Table 4. Major Players of Acellular Vaccines

Table 5. Global Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 6. Global Pertussis Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Pertussis Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Pertussis Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Pertussis Vaccine Sale Price by Type (2017-2022) & (USD/Doses)

Table 10. Global Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 11. Global Pertussis Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Pertussis Vaccine Revenue by Application (2017-2022)

Table 13. Global Pertussis Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Pertussis Vaccine Sale Price by Application (2017-2022) & (USD/Doses)

Table 15. Global Pertussis Vaccine Sales by Company (2020-2022) & (M Doses)

Table 16. Global Pertussis Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Pertussis Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Pertussis Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Pertussis Vaccine Sale Price by Company (2020-2022) & (USD/Doses)

Table 20. Key Manufacturers Pertussis Vaccine Producing Area Distribution and Sales Area

Table 21. Players Pertussis Vaccine Products Offered

Table 22. Pertussis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pertussis Vaccine Sales by Geographic Region (2017-2022) & (M Doses)

Table 26. Global Pertussis Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Pertussis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Pertussis Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Pertussis Vaccine Sales by Country/Region (2017-2022) & (M Doses)

Table 30. Global Pertussis Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Pertussis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Pertussis Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Pertussis Vaccine Sales by Country (2017-2022) & (M Doses)

Table 34. Americas Pertussis Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Pertussis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Pertussis Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 38. Americas Pertussis Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 40. Americas Pertussis Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Pertussis Vaccine Sales by Region (2017-2022) & (M Doses)

Table 42. APAC Pertussis Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Pertussis Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Pertussis Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 46. APAC Pertussis Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 48. APAC Pertussis Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Pertussis Vaccine Sales by Country (2017-2022) & (M Doses)

Table 50. Europe Pertussis Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Pertussis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Pertussis Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 54. Europe Pertussis Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 56. Europe Pertussis Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Pertussis Vaccine Sales by Country (2017-2022) & (M Doses)

Table 58. Middle East & Africa Pertussis Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Pertussis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Pertussis Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 62. Middle East & Africa Pertussis Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 64. Middle East & Africa Pertussis Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Pertussis Vaccine

Table 66. Key Market Challenges & Risks of Pertussis Vaccine

Table 67. Key Industry Trends of Pertussis Vaccine

Table 68. Pertussis Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Pertussis Vaccine Distributors List

Table 71. Pertussis Vaccine Customer List

Table 72. Global Pertussis Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 73. Global Pertussis Vaccine Sales Market Forecast by Region

Table 74. Global Pertussis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Pertussis Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Pertussis Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 77. Americas Pertussis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Pertussis Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 79. APAC Pertussis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Pertussis Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 81. Europe Pertussis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Pertussis Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 83. Middle East & Africa Pertussis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Pertussis Vaccine Sales Forecast by Type (2023-2028) & (M Doses)

Table 85. Global Pertussis Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Pertussis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Pertussis Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Pertussis Vaccine Sales Forecast by Application (2023-2028) & (M Doses)

Table 89. Global Pertussis Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Pertussis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Pertussis Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Pasteur Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Pasteur Pertussis Vaccine Product Offered

Table 94. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 95. Sanofi Pasteur Main Business

Table 96. Sanofi Pasteur Latest Developments

Table 97. GSK Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Pertussis Vaccine Product Offered

Table 99. GSK Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Mitsubishi Tanabe Pharma Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Offered

Table 104. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 105. Mitsubishi Tanabe Pharma Main Business

Table 106. Mitsubishi Tanabe Pharma Latest Developments

Table 107. Wuhan Institute of Biological Products Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Wuhan Institute of Biological Products Pertussis Vaccine Product Offered

Table 109. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 110. Wuhan Institute of Biological Products Main Business

Table 111. Wuhan Institute of Biological Products Latest Developments

Table 112. Walvax Biotechnology Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Walvax Biotechnology Pertussis Vaccine Product Offered

Table 114. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 115. Walvax Biotechnology Main Business

Table 116. Walvax Biotechnology Latest Developments

Table 117. Minhai Biotechnology Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Minhai Biotechnology Pertussis Vaccine Product Offered

Table 119. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 120. Minhai Biotechnology Main Business

Table 121. Minhai Biotechnology Latest Developments

Table 122. KM Biologics Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. KM Biologics Pertussis Vaccine Product Offered

Table 124. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 125. KM Biologics Main Business

Table 126. KM Biologics Latest Developments

Table 127. Chengdu Institute of Biological Products Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Chengdu Institute of Biological Products Pertussis Vaccine Product Offered

Table 129. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 130. Chengdu Institute of Biological Products Main Business

Table 131. Chengdu Institute of Biological Products Latest Developments

List of Figures

Figure 1. Picture of Pertussis Vaccine

Figure 2. Pertussis Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pertussis Vaccine Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Pertussis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pertussis Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Whole-cell Vaccines

Figure 10. Product Picture of Acellular Vaccines

Figure 11. Global Pertussis Vaccine Sales Market Share by Type in 2021

Figure 12. Global Pertussis Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Pertussis Vaccine Consumed in 12 Months Below

Figure 14. Global Pertussis Vaccine Market: 12 Months Below (2017-2022) & (M Doses)

Figure 15. Pertussis Vaccine Consumed in 12 Months Above

Figure 16. Global Pertussis Vaccine Market: 12 Months Above (2017-2022) & (M Doses)

Figure 17. Global Pertussis Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Pertussis Vaccine Revenue Market Share by Application in 2021

Figure 19. Pertussis Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Pertussis Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Pertussis Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Pertussis Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Pertussis Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Pertussis Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Pertussis Vaccine Sales 2017-2022 (M Doses)

Figure 26. Americas Pertussis Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Pertussis Vaccine Sales 2017-2022 (M Doses)

Figure 28. APAC Pertussis Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Pertussis Vaccine Sales 2017-2022 (M Doses)

Figure 30. Europe Pertussis Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Pertussis Vaccine Sales 2017-2022 (M Doses)

Figure 32. Middle East & Africa Pertussis Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Pertussis Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Pertussis Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Pertussis Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Pertussis Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Pertussis Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Pertussis Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Pertussis Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Pertussis Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Pertussis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Pertussis Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Pertussis Vaccine

Figure 63. Industry Chain Structure of Pertussis Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles